The Independent Advisory Group on Public Health Implications of Synthetic Biology Technology Related to Smallpox. A report to the Director-General of WHO. WHO, Geneva, Switzerland 29–30 June 2015.
WHO Advisory Committee on Variola Virus Research. Report of the Eighteenth Meeting. WHO, Geneva, Switzerland 2–3 November 2016.
Greenberg, RN, et al.
Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects. Journal of Infectious Diseases
2013; 207: 749–758.
Weinstein, RS, et al.
Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with vaccinia virus. BMC Immunology
2010; 11: 23.
Weinstein, RS, Weinstein, MM, Alibek, K, Inventors; Weinstein, RS, Weinstein, MM, Alibek, K Assignees. Compositions and methods for treating or preventing HIV infection. United States patent US20100189747 A1, 2010 July 29.
Jensen, ML, et al.
Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau. PLoS ONE
2006; 1: e101.
Aaby, P, et al.
Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau. Vaccine
2006; 24: 5718–5725.
Miedema, F, et al.
Immune activation and collateral damage in AIDS pathogenesis. Frontiers in Immunology
2013; 4: 298.
Netea, MG, Quintin, J, van der Meer, JW. Trained immunity: a memory for innate host defense. Cell Host & Microbe
2011; 9: 355–361.
Demkowicz, WE Jr., et al.
Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. Journal of Virology
1996; 70: 2627–2631.
Crotty, S, et al.
Cutting edge: long-term B cell memory in humans after smallpox vaccination. The Journal of Immunology
2003; 171: 4969–4973.
Taub, DD, et al.
Immunity from smallpox vaccine persists for decades: a longitudinal study. The American Journal of Medicine
2008; 121: 1058–1064.
Organisation Mondiale de la Santé. Analyse scientifique de la recherche sur le virus variolique, 1999–2010. OMS, Décembre 2010.
Agence Nationale de la Statistique et de la Démographie (ANSD). Enquête Démographique et de Santé à Indicateurs Multiples Sénégal (EDS-MICS) 2010–2011. Février 2012, Dakar, Sénégal.
15.République du Sénégal, Conseil National de Lutte contre le Sida. Rapport Enquête combinée chez les HSH. Dakar, Sénégal, 2014.
Wade, AS, et al.
Reduction in risk-taking behaviors among MSM in Senegal between 2004 and 2007 and prevalence of HIV and other STIs. ELIHoS Project, ANRS 12139. AIDS Care
2010; 22: 409–414.
Leprêtre, A, et al.
Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study. Journal of the International AIDS Society
2015; 18: 19888.
Who International Laboratory for Biological Standards. The International Standard for beta 2 microglobulin. WHO, Medicine and Healthcare Products Regulatory Agency, 1996.
Fine, PE, Ponnighaus, JM, Maine, N. The distribution and implications of BCG scars in northern Malawi. Bulletin of the World Health Organization
1989; 67: 35–42.
Poulsen, AG, et al.
Risk factors for HIV-2 seropositivity among older people in Guinea-Bissau. A search for the early history of HIV-2 infection. Scandinavian Journal of Infectious Diseases
2000; 32: 169–175.
Gottlieb, MS, et al. Morbidity and Mortality Weekly Report. 1981, Volume 30: pp. 250–252.
Faria, NR, et al.
HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations. Science
2014; 346: 56–61.
Kan, VL, et al.
Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection. AIDS
2007; 21: 521–524.
Rieckmann, A, et al.
Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971–2010. International Journal of Epidemiology
2017; 46: 695–705.
Sørup, S, et al.
Smallpox vaccination and all-cause infectious disease hospitalization: a Danish register-based cohort study. International Journal of Epidemiology
2011; 40: 955–963.
Hammarlund, E, et al.
Antiviral immunity following smallpox virus infection: a case-control study. Journal of Virology
2010; 84: 12754–12760.
Muraille, E. The unspecific side of acquired immunity against infectious disease: causes and consequences. Frontiers in Microbiology
2016; 6: 1525.
Gilat, T, et al.
Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scandinavian Journal of Gastroenterology
1987; 22: 1009–1024.
Kurtzke, JF, et al.
Multiple sclerosis in the Faroe Islands. 7. Results of a case control questionnaire with multiple controls. Acta Neurologica Scandinavica
1997; 96: 149–157.
Pfahlberg, A, et al.
Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. Journal of Investigative Dermatology
2002; 119: 570–575.
Kolmel, KF, et al.
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. A European organization for research and treatment of cancer cohort study on 542 patients. European Journal of Cancer
2005; 41: 118–125.
Bager, P, et al.
Smallpox vaccination and risk of atopy and asthma. Journal of Allergy and Clinical Immunology
2003; 111: 1127–1131.
Blom, L, et al.
Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia
1991; 34: 176–181.
Classen, J, Classen, DC. Immunization in the first month of life may explain decline in incidence of IDDM in The Netherlands. Autoimmunity
1999; 31: 43–45.
Mayr, A. Taking advantage of the positive side-effects of smallpox vaccination. Journal of Veterinary Medicine B Infectious Disease and Veterinary Public Health
2004; 51: 199–201.
Crum-Cianflone, NF, Sullivan, E. Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II. Infectious diseases and therapy 2017 Aug 5.
Bray, M, Buller, M. Looking back at smallpox. Clinical Infectious Diseases
2004; 38: 882–889.